Search Results - "Rushlow, W.J."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling by Sutton, L.P, Rushlow, W.J

    Published in Neuroscience (29-12-2011)
    “…Abstract Glycogen synthase kinase-3 (GSK-3) has been implicated in the action of antipsychotics, mood stabilizers, and antidepressants. Given that only…”
    Get full text
    Journal Article
  2. 2

    Chronic hyperdopaminergic activity of schizophrenia is associated with increased ΔFosB levels and cdk-5 signaling in the nucleus accumbens by Cantrup, R, Sathanantham, K, Rushlow, W.J, Rajakumar, N

    Published in Neuroscience (11-10-2012)
    “…Highlights ► Chronic hyperdopaminergic activity was studied in a rat model of schizophrenia. ► ΔFosB and cdk5 levels and their signaling were increased in the…”
    Get full text
    Journal Article
  3. 3

    Antipsychotics affect multiple calcium calmodulin dependent proteins by Rushlow, W.J, Seah, C, Sutton, L.P, Bjelica, A, Rajakumar, N

    Published in Neuroscience (07-07-2009)
    “…Abstract Calcineurin is a calmodulin (CaM) dependent protein phosphatase recently found to be altered in the brains of patients suffering from schizophrenia…”
    Get full text
    Journal Article
  4. 4

    L-type calcium channel blockade on haloperidol-induced c-Fos expression in the striatum by Lee, J, Rushlow, W.J, Rajakumar, N

    Published in Neuroscience (09-11-2007)
    “…Abstract Haloperidol-induced c-Fos expression in the lateral part of the neostriatum has been correlated with motor side effects while c-Fos induction in the…”
    Get full text
    Journal Article
  5. 5

    Characterization of CArG-binding protein A initially identified by differential display by Rushlow, W.J., Rajakumar, N., Flumerfelt, B.A., Naus, C.C.G.

    Published in Neuroscience (01-09-1999)
    “…While investigating differences in the pattern of gene expression in functionally distinct areas of the rat caudate–putamen employing differential display, we…”
    Get full text
    Journal Article
  6. 6

    Changes in CArG-binding protein A expression levels following injection(s) of the D1-dopamine agonist SKF-82958 in the intact and 6-hydroxydopamine-lesioned rat by Rushlow, W.J, Rajakumar, B, Flumerfelt, B.A, Naus, C.C.G, Rajakumar, N

    Published in Neuroscience (01-01-2000)
    “…We recently characterized the rat brain homolog of mouse muscle CArG-binding protein A initially identified in C2 myogenic cells and showed an inverse temporal…”
    Get full text
    Journal Article